# Bristol-Myers Squibb Company (NYSE: BMY), Devens, MA – FDA Inspections

Source: https://www.keypedia.com/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc

> Inspection records and compliance data for Bristol-Myers Squibb Company in Devens, Massachusetts. 8 FDA inspections on record, 4 Form 483s, last inspected August 27, 2026. Publicly traded as NYSE: BMY.

---

## Details

- Name: Bristol-Myers Squibb Company
- FEI Number: 3008455069
- Address Line 1: 38 Jackson Rd
- City: Devens
- State: Massachusetts
- Zip Code: 01434
- Country Name: United States
- Address: 38 Jackson Rd, Devens, Massachusetts 01434, United States
- Country: United States

## Stock

- Stock ticker: BMY
- Exchange: NYSE
- Share price: $62.37
- Market cap: $127.5B
- Price as of: November 13, 2026

## Related Documents

- [FDA Inspection 1338128 - Bristol-Myers Squibb Company - 2026-08-27](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/4d738ca2-e486-4320-95cb-6dde6f4ee6da) — source: FDA, date: August 27, 2026
- [483 - Bristol-Myers Squibb Company - 2025-07-08](https://www.keypedia.com/records/483/bristol-myers-squibb-company/939abfe3-3ecc-4e4d-8c08-1fef2cc2e38d) — source: FDA, date: July 8, 2025
- [FDA Inspection 1272436 - Bristol-Myers Squibb Company - 2025-07-08](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/0aa1d66a-a76f-4fa2-92d8-ffeac1db7331) — source: FDA, date: July 8, 2025
- FDA Inspection 1272436 - Bristol-Myers Squibb Company - 2025-07-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 8, 2025
- [483 - Bristol-Myers Squibb Company - 2023-05-05](https://www.keypedia.com/records/483/bristol-myers-squibb-company/a7910c72-02d4-4e79-b454-32680a26de2f) — source: FDA, date: May 5, 2023
- [FDA Inspection 1206159 - Bristol-Myers Squibb Company - 2023-05-05](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/2b8d62b7-f73a-4fd8-bb70-69b6edafbbad) — source: FDA, date: May 5, 2023
- FDA Inspection 1115960 - Bristol-Myers Squibb Company - 2020-01-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 10, 2020
- [FDA Inspection 1008167 - Bristol-Myers Squibb Company - 2017-04-05](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/8a6b3347-61a7-4888-b4e1-003a1e2120e8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2017
- FDA Inspection 988152 - Bristol-Myers Squibb Company - 2016-10-21 — source: FDA, date: October 21, 2016
- FDA Inspection 932048 - Bristol-Myers Squibb Company - 2015-06-26 — classification: No Action Indicated (NAI), source: FDA, date: June 26, 2015
- FDA Inspection 836877 - Bristol-Myers Squibb Company - 2013-06-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2013

## Related Companies

- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Amgen, Inc.](https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Sumitomo Dainippon Pharma Co., Ltd.](https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf)

## Related Officers

- [Viviana R. Ramirez](https://www.keypedia.com/people/viviana-r-ramirez/1d34f713-edc8-4776-ad70-28fcd59345de)
- [Gideon Prave](https://www.keypedia.com/people/gideon-prave/8fd301fb-8b88-45a5-b7cd-e4e955a53280)
- [Senior Consumer Safety Officer - Pharmaceutical Quality](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)
- [Armen H. Youssoufian](https://www.keypedia.com/people/armen-h-youssoufian/47aa0283-ca67-4aec-8ac1-7d4cb222eb04)
